Maravai LifeSciences Holdings, Inc.
MRVI stock score: 44/100
$7.07 · -6.61% · Scored Oct 22, 2026
- Technical
- 58
- Fundamental
- 31
- News
- —
The reading
Maravai LifeSciences (MRVI) scores 44 out of 100, which reads weak, higher than 45% of Healthcare stocks and 28% of the 4,166 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 58, fundamentals 31.
Among the fundamentals, Fund Ownership at 100 and Price Target at 99 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.
On the daily chart, trend-following indicators average 50 and contrarian oscillators 52.
Since Jul 25, 2026 the composite has ranged from 41 to 65, and it is down 21 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward MRVI’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
31Pulling it up
- Fund Ownership100
Fund ownership tracks institutional investor holdings and changes.
- Price Target99
Price target score compares the current stock price to analyst consensus targets.
- Current Ratio98
Current ratio measures ability to pay short-term liabilities with current assets.
Holding it back
- Earnings Profitability (Quarterly)0
Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.
- Earnings Quality (Annual)0
Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.
- Earnings Growth (5-Year)0
5-year earnings growth evaluates long-term profit trajectory and consistency.
40 weighted scorers; 1 had no data today and are left out rather than counted as zero.
Technical · daily
52Pulling it up
- 52-Week Change100
The price change over the last 52 weeks.
- S&P 500 52W Comparison100
S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.
- SMA 20098
Simple Moving Average (200-period) is the most widely followed long-term trend indicator.
Holding it back
- Ichimoku Cloud0
Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.
- Parabolic SAR (PSAR)0
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- VWAP8
Volume Weighted Average Price (VWAP) shows the average price weighted by volume.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 40 | 1 |
| Daily | 52 | 3 |
| Weekly | 62 | 2 |
| Monthly | 65 | 2 |
| Quarterly | 62 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 44 |
| Oct 21, 2026 | 48 |
| Oct 20, 2026 | 46 |
| Oct 19, 2026 | 44 |
| Oct 18, 2026 | 44 |
| Oct 17, 2026 | 44 |
| Oct 16, 2026 | 43 |
| Oct 15, 2026 | 44 |
| Oct 14, 2026 | 41 |
| Oct 13, 2026 | 42 |
| Oct 12, 2026 | 44 |
| Oct 11, 2026 | 46 |
| Oct 10, 2026 | 46 |
| Oct 9, 2026 | 46 |
| Oct 8, 2026 | 45 |
| Oct 7, 2026 | 46 |
| Oct 6, 2026 | 48 |
| Oct 5, 2026 | 48 |
| Oct 4, 2026 | 48 |
| Oct 3, 2026 | 47 |
| Oct 2, 2026 | 47 |
| Oct 1, 2026 | 46 |
| Sep 30, 2026 | 47 |
| Sep 29, 2026 | 47 |
| Sep 28, 2026 | 47 |
| Sep 27, 2026 | 47 |
| Sep 26, 2026 | 47 |
| Sep 25, 2026 | 46 |
| Sep 24, 2026 | 47 |
| Sep 23, 2026 | 46 |
| Sep 22, 2026 | 46 |
| Sep 21, 2026 | 46 |
| Sep 20, 2026 | 45 |
| Sep 19, 2026 | 45 |
| Sep 18, 2026 | 45 |
| Sep 17, 2026 | 46 |
| Sep 16, 2026 | 44 |
| Sep 15, 2026 | 45 |
| Sep 14, 2026 | 43 |
| Sep 13, 2026 | 43 |
| Sep 12, 2026 | 43 |
| Sep 11, 2026 | 43 |
| Sep 10, 2026 | 42 |
| Sep 9, 2026 | 43 |
| Sep 8, 2026 | 45 |
| Sep 7, 2026 | 45 |
| Sep 6, 2026 | 45 |
| Sep 5, 2026 | 45 |
| Sep 4, 2026 | 46 |
| Sep 3, 2026 | 45 |
| Sep 2, 2026 | 47 |
| Sep 1, 2026 | 46 |
| Aug 31, 2026 | 46 |
| Aug 30, 2026 | 46 |
| Aug 29, 2026 | 46 |
| Aug 28, 2026 | 46 |
| Aug 27, 2026 | 47 |
| Aug 26, 2026 | 48 |
| Aug 25, 2026 | 49 |
| Aug 24, 2026 | 47 |
| Aug 23, 2026 | 48 |
| Aug 19, 2026 | 50 |
| Aug 18, 2026 | 45 |
| Aug 17, 2026 | 44 |
| Aug 16, 2026 | 44 |
| Aug 15, 2026 | 44 |
| Aug 14, 2026 | 44 |
| Aug 13, 2026 | 46 |
| Aug 12, 2026 | 44 |
| Aug 11, 2026 | 44 |
| Aug 10, 2026 | 46 |
| Aug 9, 2026 | 46 |
| Aug 8, 2026 | 44 |
| Aug 7, 2026 | 45 |
| Aug 6, 2026 | 45 |
| Aug 5, 2026 | 46 |
| Aug 3, 2026 | 46 |
| Aug 2, 2026 | 47 |
| Jul 31, 2026 | 63 |
| Jul 30, 2026 | 64 |
| Jul 29, 2026 | 64 |
| Jul 28, 2026 | 65 |
| Jul 27, 2026 | 65 |
| Jul 26, 2026 | 65 |
| Jul 25, 2026 | 65 |
Key facts
- Market cap
- $2.6B
- Sector
- Healthcare
- Industry
- Biotechnology
- Beta
- 0.54
- Risk grade (1–10)
- 10
- Next earnings
- Nov 4, 2026
Biotechnology peers
| Company | Market cap | Score |
|---|---|---|
| CELC Celcuity | $3.0B | 35 |
| DYN Dyne Therapeutics | $3.0B | 35 |
| DNLI Denali Therapeutics | $3.0B | 37 |
| IRON Disc Medicine | $2.9B | 46 |
| NRIX Nurix Therapeutics | $2.8B | 64 |
| ZLAB Zai Lab | $2.7B | 43 |
Questions
What is MRVI's stock score today?
MRVI scores 44/100 (Weak) as of Oct 22, 2026: technical 58, fundamental 31. Scores are recomputed every night.
Is MRVI a buy?
The score is not a buy or sell recommendation. A 44 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the MRVI score calculated?
101 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.